Episode

Ep204: Troy Wilson on Precision Cancer Drugs and Combos

Podcast: The Long Run with Luke Timmerman
Published: Jun 30, 2026
Duration seconds: 4047
Processing state: not_requested
Canonical source: https://soundcloud.com/longrunpodcast/ep204-troy-wilson-on-precision
Audio: https://feeds.soundcloud.com/stream/2350687799-longrunpodcast-ep204-troy-wilson-on-precision.mp3
JSON: /v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep204-troy-wilson-on-precision-cancer-drugs-and-combos
Markdown: /podcast/the-long-run-with-luke-timmerman-1124799/ep204-troy-wilson-on-precision-cancer-drugs-and-combos.md

Actions

POST https://stenobird.com/v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep204-troy-wilson-on-precision-cancer-drugs-and-combos/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep204-troy-wilson-on-precision-cancer-drugs-and-combos.md
Read the agent-friendly Markdown representation of this episode resource.

Troy Wilson, CEO of San Diego-based Kura Oncology, on his career in biotech and developing targeted cancer drugs.